683 Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Sell |
2,160,000
-251,400
| -10% | -$1.61M | 0.91% | 18 |
|
|
2025
Q1 | $8.54M | Buy |
2,411,400
+481,400
| +25% | +$1.7M | 0.59% | 40 |
|
|
2024
Q4 | $7.3M | Sell |
1,930,000
-70,000
| -4% | -$265K | 0.45% | 44 |
|
|
2024
Q3 | $6.48M | Buy |
2,000,000
+498,129
| +33% | +$1.61M | 0.49% | 47 |
|
|
2024
Q2 | $2.85M | Buy |
+1,501,871
| New | +$2.85M | 0.22% | 66 |
|
|
2022
Q3 | – | Sell |
-677,714
| Closed | -$13M | – | 238 |
|
|
2022
Q2 | $13M | Hold |
677,714
| – | – | 0.92% | 34 |
|
|
2022
Q1 | $7.69M | Buy |
+677,714
| New | +$7.69M | 0.41% | 60 |
|